Literature DB >> 22285513

Angiotensin-(1-7) receptor Mas is an essential modulator of extracellular matrix protein expression in the heart.

Elisandra Gava1, Carlos Henrique de Castro, Anderson J Ferreira, Heloísa Colleta, Marcos B Melo, Natalia Alenina, Michael Bader, Laser A Oliveira, Robson A S Santos, Gregory T Kitten.   

Abstract

In this study we investigated the effects of genetic deletion of the Angiotensin-(1-7) receptor Mas or the Angiotensin II receptor AT(2) on the expression of specific extracellular matrix (ECM) proteins in atria, right ventricles and atrioventricular (AV) valves of neonatal and adult mice. Quantification of collagen types I, III and VI and fibronectin was performed using immunofluorescence-labeling and confocal microscopy. Picrosirius red staining was used for the histological assessment of the overall collagen distribution pattern. ECM proteins, metalloproteinases (MMP), ERK1/2 and p38 levels were quantified by western blot analysis. Gelatin zymography was used to evaluate the activity of MMP-2 and MMP-9. We observed that the relative levels of collagen types I and III and fibronectin are significantly higher in both the right ventricle and AV valves of neonatal Mas(-/-) mouse hearts (e.g., collagen type I: 85.28±6.66 vs 43.50±4.41 arbitrary units in the right ventricles of Mas(+/+) mice). Conversely, the level of collagen type VI was lower in the right ventricle and AV valves of Mas(-/-) mice. Adult Mas(-/-) mouse hearts presented similar patterns as observed in neonates. No significant differences in ECM protein level were detected in atria. Likewise, no changes in ECM levels were observed in AT(2) knockout mouse hearts. Although deletion of Mas induced a significant reduction in the level of the active form of MMP-2 in neonate hearts and a reduction of both MMP-2 and MMP-9 in adult Mas(-/-) mice, no significant differences were observed in MMP enzymatic activities when compared to controls. The levels of the active, phosphorylated forms of ERK1/2 and p38 were higher in hearts of both neonatal and adult Mas(-/-) mice. These observations suggest that Mas is involved in the selective expression of specific ECM proteins within both the ventricular myocardium and AV valves. The changes in the ECM profile may alter the connective tissue framework and contribute to the decreased cardiac performance observed in Mas(-/-) mice. Copyright Â
© 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22285513     DOI: 10.1016/j.regpep.2012.01.001

Source DB:  PubMed          Journal:  Regul Pept        ISSN: 0167-0115


  16 in total

Review 1.  International Union of Basic and Clinical Pharmacology. XCIX. Angiotensin Receptors: Interpreters of Pathophysiological Angiotensinergic Stimuli [corrected].

Authors:  Sadashiva S Karnik; Hamiyet Unal; Jacqueline R Kemp; Kalyan C Tirupula; Satoru Eguchi; Patrick M L Vanderheyden; Walter G Thomas
Journal:  Pharmacol Rev       Date:  2015-10       Impact factor: 25.468

2.  Differential effects of Mas receptor deficiency on cardiac function and blood pressure in obese male and female mice.

Authors:  Yu Wang; Robin Shoemaker; David Powell; Wen Su; Sean Thatcher; Lisa Cassis
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-12-16       Impact factor: 4.733

3.  Protective role of ACE2-Ang-(1-7)-Mas in myocardial fibrosis by downregulating KCa3.1 channel via ERK1/2 pathway.

Authors:  Li-Ping Wang; Su-Jing Fan; Shu-Min Li; Xiao-Jun Wang; Jun-Ling Gao; Xiu-Hong Yang
Journal:  Pflugers Arch       Date:  2016-09-03       Impact factor: 3.657

Review 4.  The ACE2/Angiotensin-(1-7)/MAS Axis of the Renin-Angiotensin System: Focus on Angiotensin-(1-7).

Authors:  Robson Augusto Souza Santos; Walkyria Oliveira Sampaio; Andreia C Alzamora; Daisy Motta-Santos; Natalia Alenina; Michael Bader; Maria Jose Campagnole-Santos
Journal:  Physiol Rev       Date:  2018-01-01       Impact factor: 37.312

Review 5.  ACE2, angiotensin-(1-7) and Mas receptor axis in inflammation and fibrosis.

Authors:  A C Simões e Silva; K D Silveira; A J Ferreira; M M Teixeira
Journal:  Br J Pharmacol       Date:  2013-06       Impact factor: 8.739

Review 6.  Opportunities for targeting the angiotensin-converting enzyme 2/angiotensin-(1-7)/mas receptor pathway in hypertension.

Authors:  Rodrigo Araujo Fraga-Silva; Anderson Jose Ferreira; Robson Augusto Souza Dos Santos
Journal:  Curr Hypertens Rep       Date:  2013-02       Impact factor: 5.369

Review 7.  ACE2, angiotensin-(1–7), and Mas: the other side of the coin.

Authors:  Michael Bader
Journal:  Pflugers Arch       Date:  2013-01       Impact factor: 3.657

8.  Succinate causes pathological cardiomyocyte hypertrophy through GPR91 activation.

Authors:  Carla J Aguiar; João A Rocha-Franco; Pedro A Sousa; Anderson K Santos; Marina Ladeira; Cibele Rocha-Resende; Luiz O Ladeira; Rodrigo R Resende; Fernando A Botoni; Marcos Barrouin Melo; Cristiano X Lima; José M Carballido; Thiago M Cunha; Gustavo B Menezes; Silvia Guatimosim; M Fatima Leite
Journal:  Cell Commun Signal       Date:  2014-12-24       Impact factor: 5.712

9.  Atypical signaling and functional desensitization response of MAS receptor to peptide ligands.

Authors:  Kalyan C Tirupula; Russell Desnoyer; Robert C Speth; Sadashiva S Karnik
Journal:  PLoS One       Date:  2014-07-28       Impact factor: 3.240

10.  Cholinergic signaling exerts protective effects in models of sympathetic hyperactivity-induced cardiac dysfunction.

Authors:  Mariana Gavioli; Aline Lara; Pedro W M Almeida; Augusto Martins Lima; Denis D Damasceno; Cibele Rocha-Resende; Marina Ladeira; Rodrigo R Resende; Patricia M Martinelli; Marcos Barrouin Melo; Patricia C Brum; Marco Antonio Peliky Fontes; Robson A Souza Santos; Marco A M Prado; Silvia Guatimosim
Journal:  PLoS One       Date:  2014-07-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.